Active Trials Archives | Page 3 of 3

Novartis CRTH258A2303 TALON

Research Title: A 64-week, Two-arm, Randomized, Double-masked, Multicenter, Phase IIIb Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen in Patients with Neovascular Agerelated Macular Degeneration (TALON) Sponsor: Novartis Pharmaceuticals Principal Investigator: Robert Stoltz, M.D., Ph.D. Description: The study is a 64-week randomized, double-masked, multi-center, active-controlled, two-arm study in…

What Our Patients Say

"I would first like to say, that it is a pleasure coming every month to get my eye injections solely based on the staff and my retina specialist! They are always so sweet, well educated, and very welcoming!"

- Hayley

"The staff is kind and very well informed. They walk you through exactly what is happening and give you all your options upfront (including financials). I would 100% recommend and I will be back for an annual checkup!"

- Pardis

"I have a great experience with Georgia Retina staff they make me feel right at home when I walk through the doors."

- Michael

"Dr. Stallman is an excellent physician. The staff in this office give excellent service extrodinar. They are all very kind, professional, and genuinely concerned about your care. Love these folks!"

- Vale

"Very few doctors today display the confidence in their ability that Dr Mukkamala has. And does this without arrogance. He explains a complicated procedure and is sure that you understand when he finishes. I highly recommend him if you need this type of care."

- David

Active Trials

Novartis CRTH258A2303 TALON

Testimonials

What Our Patients Say